CoChat
Sign Up
Cited by 348

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Role of Ras and Mapks in TGFβ signaling

Mulder, Kathleen M·2000·Cytokine & Growth Factor Reviews
DOI 10.1016/s1359-6101(99)00026-x
Open this paper in CoChat — free account

Abstract

Normal signaling by TGFbeta, in the absence of serum or exogenous factors, involves a rapid activation of Ras, Erks, and Sapks in proliferating cultures of TGFbeta-sensitive untransformed epithelial cells and human carcinoma cells. Expression of either RasN17 or dominant-negative (DN) MKK4, or addition of the MEK1 inhibitor PD98059, can block the ability of TGFbeta to induce AP-1 complex formation at the TGFbeta(1) promoter and to autoinduce its own production. The primary components present in this TGFbeta-stimulated AP-1 complex are JunD and Fra-2, although c-Jun, and possibly Fos B, may also be present. While there are two potential Smad binding elements (SBE's) in the TGFbeta(1) promoter, supershift assays suggest that at least one of these does not bind Smad4, and the other is unable to bind factors activated by TGFbeta. In contrast, TGFbeta autoinduction is Smad3-dependent, as DN Smad3 inhibits the ability of TGFbeta to stimulate TGFbeta(1) promoter activity. Our results indicate that TGFbeta can activate both the MKK4/Sapk and MEK/Erk pathways, through Ras and TGFbeta R(I) and R(II), to induce TGFbeta(1) production; Smad4 does not appear to be involved, and Smad3 appears to function independently of this Smad4. We also demonstrate that activation of the Ras/Mapk pathway by TGFbeta positively modulates Smad1-signaling-pathway activation by TGFbeta. In addition, Smad1 could enhance TGFbeta activation of the SBE reporter SBE-luc and this effect could be blocked by co-expr…

Overview

Integrity signals

Registry

Crossref · 10.1016/s1359-6101(99)00026-x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 3 references

Research works printed but not linked: 78

  1. Davis, 1993, The mitogen-activated protein kinase signal transduction pathway, J. Biol. Chem., 268, 14,553, 10.1016/S0021-9258(18)82362-6 · DOI
  2. Marshall, 1994, Mapk kinase kinase, Mapk kinase and Mapk, Curr. Opin. Genet. Dev., 4, 82, 10.1016/0959-437X(94)90095-7 · DOI
  3. Robinson, 1997, Mitogen-activated protein kinase pathways, Curr. Opin. Cell. Biol., 9, 180, 10.1016/S0955-0674(97)80061-0 · DOI
  4. Dérijard, 1994, JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain, Cell., 76, 1025, 10.1016/0092-8674(94)90380-8 · DOI · Paper page
  5. Russell, 1995, Direct interaction between Ras and the kinase domain of mitogen-activated protein kinase kinase kinase (MEKK1), J. Biol. Chem., 270, 11,757, 10.1074/jbc.270.20.11757 · DOI
  6. Weinberg, 1997, The cat and mouse games that genes, viruses, and cells play, Cell., 88, 573, 10.1016/S0092-8674(00)81897-8 · DOI
  7. Mulcahay, 1985, Requirement for ras protooncogene function during serum stimulated growth of NIH 3T3 cells, Nature, 313, 241, 10.1038/313241a0 · DOI
  8. Hagag, 1986, Inhibition of growth factor induced differentiation of PC12 cells by microinjection of antibody to ras p21, Nature, 319, 680, 10.1038/319680a0 · DOI
  9. Dikic, 1994, PC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation, Curr. Biol., 4, 702, 10.1016/S0960-9822(00)00155-X · DOI
  10. Traverse, 1994, EGF triggers neural differentiation of PC12 cells that overexpress the EGF receptor, Curr. Biol., 4, 694, 10.1016/S0960-9822(00)00154-8 · DOI
  11. Chen, 1995, Direction of p21ras-generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2, Oncogene., 11, 1487
  12. Joneson, 1999, Suppression of Ras-induced apoptosis by the Rac GTPase, Mol. Cell. Biol., 19, 5892, 10.1128/MCB.19.9.5892 · DOI
  13. Howe, 1993, Release from G1 growth arrest by transforming growth factor beta 1 requires cellular ras activity, J. Biol. Chem., 268, 21,448, 10.1016/S0021-9258(19)36945-5 · DOI
  14. Atfi, 1994, Transforming growth factor β down-regulates Src family protein tyrosine kinase signaling pathways, J. Biol. Chem., 269, 30,688, 10.1016/S0021-9258(18)43868-9 · DOI
  15. Hartsough, 1995, Transforming growth factor β activation of p44mapk in proliferating cultures of epithelial cells, J. Biol. Chem., 270, 7117, 10.1074/jbc.270.13.7117 · DOI
  16. Chatani, 1995, Cell type-specific modulation of cell growth by transforming growth factor β1 does not correlate with mitogen-activated protein kinase activation, J. Biol. Chem., 270, 30,686, 10.1074/jbc.270.51.30686 · DOI
  17. Hartsough, 1997, TGFβ signaling in epithelial cells, Pharmacol. and Ther., 75, 21, 10.1016/S0163-7258(97)00020-X · DOI
  18. Filmus, 1992, Overexpression of H-ras oncogene induces resistance to the growth-inhibitory action of transforming growth factor beta-1 (TGF-β1) and alters the number and type of TGF-β1 receptors in rat intestinal epithelial cell clones, Oncogene., 7, 521
  19. Longstreet, 1992, Loss of transforming growth factor β1 (TGF-β1)-induced growth arrest and p34cdc2 regulation in ras-transfected epithelial cells, Oncogene., 7, 1549
  20. Coppa, 1997, Restored expression of transforming growth factor β Type II receptor in k-ras-transformed thyroid cells, TGFβ-resistant, reverts their malignant phenotype, J. Cell. Physiol., 172, 200, 10.1002/(SICI)1097-4652(199708)172:2<200::AID-JCP7>3.0.CO;2-S · DOI
  21. Huggett, 1990, Altered responsiveness of rat liver epithelial cells to transforming growth factor β1 following their transformation with v-raf, Cancer Res, 50, 7468
  22. Oft, 1996, TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells, Genes. and Dev., 10, 2462, 10.1101/gad.10.19.2462 · DOI
  23. Kerr, 1991, The effect of H-ras oncogene transfection on response of mink lung epithelial cells to growth factors and cytotoxic drugs, Anticancer. Res., 11, 1349
  24. Brown, 1999, MEKK-1, a component of the stress (stress-activated protein kinase/c-Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells, J. Biol. Chem., 274, 8797, 10.1074/jbc.274.13.8797 · DOI
  25. Magee, 1999, New insights into the interaction of ras with the plasma membrane, Cell., 98, 9, 10.1016/S0092-8674(00)80601-7 · DOI
  26. Mulder, 1992, Activation of p21ras by transforming growth factor β in epithelial cells, J. Biol. Chem., 267, 5029, 10.1016/S0021-9258(18)42722-6 · DOI
  27. Yan, 1994, Two different signal transduction pathways can be activated by transforming growth factor beta 1 in epithelial cells, J. Biol. Chem., 269, 13,231, 10.1016/S0021-9258(17)36823-0 · DOI
  28. Bhushan, 1994, The transforming growth factor β type II receptor can replace the activin type II receptor in inducing mesoderm, Molecular and Cellular Biology, 14, 4280, 10.1128/MCB.14.6.4280 · DOI
  29. Mulder, 1993, Role of receptor complexes in resistance or sensitivity to growth inhibition by TGFβ in intestinal epithelial cell clones, J. Cell. Physiol., 154, 162, 10.1002/jcp.1041540120 · DOI
  30. Heasley, 1992, The β-PDGF receptor induces neuronal differentiation of PC12 cells, Molecular Biology of the Cell, 3, 545, 10.1091/mbc.3.5.545 · DOI
  31. Marshall, 1995, Specificity of receptor tyrosine kinase signaling: transient vs sustained extracellular signal-regulated kinase activation, Cell, 80, 179, 10.1016/0092-8674(95)90401-8 · DOI · Paper page
  32. Hill, 1995, Transcriptional regulation by extracellular signals: mechanisms and specificity, Cell., 80, 199, 10.1016/0092-8674(95)90403-4 · DOI · Paper page
  33. Frey, 1997, Involvement of ERK2 and Sapk/JNK activation by TGFβ in the negative growth control of breast cancer cells, Cancer Res., 57, 628
  34. Frey, 1997, TGFβ regulation of mitogen-activated protein kinases in human breast cancer cells, Cancer Lett., 117, 41, 10.1016/S0304-3835(97)00211-5 · DOI
  35. Wu, 1992, TGF-β1 is an autocrine negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an anti-sense expression vector, J. Cell. Biol., 116, 187, 10.1083/jcb.116.1.187 · DOI
  36. Kim, 1990, Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex, Mol. Cell. Biol., 10, 1492, 10.1128/MCB.10.4.1492 · DOI · Paper page
  37. Barnard, 1989, Regulation of intestinal epithelial cell growth by transforming growth factor type beta, Proc. Natl. Acad. Sci. USA, 86, 1578, 10.1073/pnas.86.5.1578 · DOI
  38. Pertovaara, 1989, Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation, Mol. Cell. Biol., 9, 1255, 10.1128/MCB.9.3.1255 · DOI
  39. Hsu, 1994, Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression, Cell Growth and Differen., 5, 267
  40. Hartsough, 1996, Altered TGFβ signaling in epithelial cells when Ras activation is blocked, J. Biol. Chem., 271, 22,368, 10.1074/jbc.271.37.22368 · DOI
  41. Yue, 1998, Blockade of TGFβ up-regulation of p27Kip1 and p21Cip1 by expression of RasN17 in epithelial cells, Oncogene., 17, 47, 10.1038/sj.onc.1201903 · DOI
  42. Buard, 1996, Maintenance of growth factor signaling through Ras in human colon carcinoma cells containing K-ras mutations, Int. J. Cancer, 67, 539, 10.1002/(SICI)1097-0215(19960807)67:4<539::AID-IJC13>3.0.CO;2-2 · DOI
  43. Mulder, 1989, Effects of growth stimulatory factors on mitogenicity and c-myc expression in poorly-differentiated and well-differentiated human colon carcinoma cells, Mol. Endocrinol., 3, 1215, 10.1210/mend-3-8-1215 · DOI
  44. Mulder, 1990, Evidence for c-myc in the signaling pathway for TGF-β in well-differentiated human colon carcinoma cells, J. Cell. Physiol., 145, 501, 10.1002/jcp.1041450316 · DOI
  45. Mulder, 1991, Differential regulation of c-myc and TGF-β mRNA expression in poorly differentiated and well-differentiated colon carcinoma cells during the establishment of a quiescent state, Cancer Res., 51, 2256
  46. Zipfel, 1993, Up-regulation of TGFα expression by TGFβ1, EGF, and DMF in human colon carcinoma cells, Cell Growth Differen., 4, 637
  47. Mulder, 1990, Inhibitory effects of transforming growth factor-β1 on mitogenic response, transforming growth factor-α, and c-myc in well-differentiated human colon carcinoma cells, Cancer Res., 50, 7581
  48. Fearon, 1990, A genetic model for colorectal tumorigenesis, Cell, 61, 759, 10.1016/0092-8674(90)90186-I · DOI · Paper page
  49. Williams, 1993, In vitro models of human colorectal cancer, Cancer Surv., 16, 15
  50. Johnson, 1997, K-ras is an esssential gene in the mouse with partial functional overlap with N-ras, Genes. and Dev., 11, 2468, 10.1101/gad.11.19.2468 · DOI
  51. Chesa, 1987, Expression of p21ras in normal and malignant human tissues: lack of association with proliferation and malignancy, Proc. Natl. Acad. Sci. USA, 84, 3234, 10.1073/pnas.84.10.3234 · DOI
  52. Furth, 1987, Expression of ras proto-oncogene proteins in normal human tissues, Oncogene., 1, 47
  53. Leon, 1987, Differential expression of the ras gene family in mice, Mol. Cell. Biol., 7, 1535, 10.1128/MCB.7.4.1535 · DOI
  54. Bos, 1989, Ras oncogenes in human cancer: a review, Cancer Res., 49, 4682
  55. Yue J, Mulder KM. Requirement of Ras/Mapk pathways for TGFβ1 autoinduction in a Smad3-dependent pathway, J Biol Chem, In press
  56. Hocevar, 1999, TGFβ induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway, EMBO J., 18, 1345, 10.1093/emboj/18.5.1345 · DOI
  57. Yue, 1999, Cloning and expression of a rat Smad1: Regulation by TGFβ and modulation by the Ras/MEK pathways, J. Cell. Physiol., 178, 387, 10.1002/(SICI)1097-4652(199903)178:3<387::AID-JCP13>3.0.CO;2-8 · DOI
  58. Yue, 1999, Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFβ, Oncogene., 18, 2033, 10.1038/sj.onc.1202521 · DOI
  59. Yan, 1994, Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1, Nature, 372, 798, 10.1038/372798a0 · DOI
  60. Sanchez, 1994, Role of SAPK/ERK kinase-1 in the stress activated pathway regulating transcription factor c-Jun, Nature, 372, 794, 10.1038/372794a0 · DOI
  61. Tibbles, 1999, The stress-activated protein kinase pathways, Cell. Mol. Life Sci., 55, 1230, 10.1007/s000180050369 · DOI
  62. Virolle, 1998, Three activator protein-1-binding sites bound by the Fra-2-JunD complex cooperate for the regulation of murine laminin α3A (Lamα3A) promoter activity by transforming growth factor β, J. Biol. Chem., 273, 17,318, 10.1074/jbc.273.28.17318 · DOI
  63. Pfarr, 1994, Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras, Cell, 76, 747, 10.1016/0092-8674(94)90513-4 · DOI
  64. Matsui, 1990, Isolation of human fos-related genes and their expression during monocyte-macrophage differentiation, Oncogene., 5, 249
  65. Riesgo-Escovar, 1997, Drosophila Jun kinase regulates expression of decapentaplegic via the ETS-domain protein Aop and the AP-1 transcription factor Djun during dorsal closure, Genes. and Dev., 11, 1717, 10.1101/gad.11.13.1717 · DOI
  66. Hou, 1997, Drosophila Jun relays the Jun amino-terminal kinase signal transduction pathway to the Decapentaplegic signal transduction pathway in regulating epithelial cell sheet movement, Genes. and Dev., 11, 1728, 10.1101/gad.11.13.1728 · DOI
  67. Noselli, 1998, JNK signaling and morphogenesis in Drosophila, Trends Genet., 14, 33, 10.1016/S0168-9525(97)01320-6 · DOI
  68. Witsotzkey, 1998, Medea is a Drosophila Smad4 homolog that is differentially required to potentiate DPP responses, Development, 125, 1433, 10.1242/dev.125.8.1433 · DOI
  69. Chen, 1996, Regulation of transforming growth factor-β and activin-induced transcription by mammalian Mad proteins, Proc. Natl. Acad. Sci. USA, 93, 12,992, 10.1073/pnas.93.23.12992 · DOI
  70. Liu, 1998, TGFβ signaling through Smad1 in human breast cancer cells, Cancer Res., 58, 4752
  71. Tsukazaki, 1998, SARA, a FYVE domain protein that recruits Smad2 to the TGF beta receptor, Cell, 95, 779, 10.1016/S0092-8674(00)81701-8 · DOI
  72. Peterson, 1999, Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization, EMBO J., 18, 804
  73. Biggs, 1999, Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1, Proc. Natl. Acad. Sci. USA, 96, 7421, 10.1073/pnas.96.13.7421 · DOI
  74. Le Gallic, 1999, Transcriptional repressor ERF is a Ras/mitogen-activated protein kinase target that regulates cellular proliferation, Mol. Cell. Biol., 19, 4121, 10.1128/MCB.19.6.4121 · DOI
  75. Itoh, 1998, Transforming growth factor beta1 induces nuclear export of inhibitory Smad7, J. Biol. Chem., 273, 29,195, 10.1074/jbc.273.44.29195 · DOI
  76. Macias-Silva, 1996, MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling, Cell, 87, 1215, 10.1016/S0092-8674(00)81817-6 · DOI
  77. Hoodless, 1996, MADR1, a MAD-related protein that functions in BMP2 signaling pathways, Cell, 85, 489, 10.1016/S0092-8674(00)81250-7 · DOI
  78. Ferreli, 1996, Tripping the switch fantastic: how a protein kinase cascade can convert graded inputs into switch-like outputs, Trends Biochem Sci, 21, 460, 10.1016/S0968-0004(96)20026-X · DOI

Cited by

Sorted by citations

See all 348

Metadata

Authors
Mulder, K. M.
Venue
Cytokine & Growth Factor Reviews
Publisher
Elsevier BV
Published
2000-04
Volume
11
Issue
1-2
Pages
23-35
ISSN
1359-6101
DOI
10.1016/s1359-6101(99)00026-x
Cited by
348
References
3
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review